135 related articles for article (PubMed ID: 30365141)
21. Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-Smad2/3 signaling.
Xu H; Sun Y; You B; Huang CP; Ye D; Chang C
Cancer Lett; 2020 Mar; 472():151-164. PubMed ID: 31846689
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
24. miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer.
Huang H; Sun P; Lei Z; Li M; Wang Y; Zhang HT; Liu J
Tumour Biol; 2015 Jun; 36(6):4123-31. PubMed ID: 25578496
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer.
Song L; Xie X; Yu S; Peng F; Peng L
Mol Med Rep; 2016 Feb; 13(2):1204-10. PubMed ID: 26677064
[TBL] [Abstract][Full Text] [Related]
26. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
Xiang J; Bian C; Wang H; Huang S; Wu D
J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
[TBL] [Abstract][Full Text] [Related]
27. Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.
Goto Y; Kojima S; Kurozumi A; Kato M; Okato A; Matsushita R; Ichikawa T; Seki N
Br J Cancer; 2016 May; 114(10):1135-44. PubMed ID: 27070713
[TBL] [Abstract][Full Text] [Related]
28. microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.
Kong X; Qian X; Duan L; Liu H; Zhu Y; Qi J
DNA Cell Biol; 2016 Dec; 35(12):828-835. PubMed ID: 27673408
[TBL] [Abstract][Full Text] [Related]
29. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
[TBL] [Abstract][Full Text] [Related]
30. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.
Siu MK; Tsai YC; Chang YS; Yin JJ; Suau F; Chen WY; Liu YN
Oncogene; 2015 Sep; 34(36):4767-76. PubMed ID: 25531317
[TBL] [Abstract][Full Text] [Related]
33. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.
Kroiss A; Vincent S; Decaussin-Petrucci M; Meugnier E; Viallet J; Ruffion A; Chalmel F; Samarut J; Allioli N
Oncogene; 2015 May; 34(22):2846-55. PubMed ID: 25065599
[TBL] [Abstract][Full Text] [Related]
34. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
[TBL] [Abstract][Full Text] [Related]
35. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
Meng FJ; Meng FM; Wu HX; Cao XF
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
[TBL] [Abstract][Full Text] [Related]
36. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
38. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
39. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
Guan Y; Wu Y; Liu Y; Ni J; Nong S
Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
[TBL] [Abstract][Full Text] [Related]
40. microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.
Li CL; Nie H; Wang M; Su LP; Li JF; Yu YY; Yan M; Qu QL; Zhu ZG; Liu BY
Oncol Rep; 2012 Jun; 27(6):1960-6. PubMed ID: 22426647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
